These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Abnormal creatine-phosphokinase isoenzyme pattern in families with malignant hyperpyrexia. Zsigmond EK; Starkweather WH; Duboff GS; Flynn KA Anesth Analg; 1972; 51(5):827-40. PubMed ID: 4672179 [No Abstract] [Full Text] [Related]
27. Elevated serum-creatine phosphokinase activity in a family with malignant hyperpyrexia. Zsigmond EK; Starkweather WH; Duboff GS; Flynn K Anesth Analg; 1972; 51(2):220-5. PubMed ID: 5062123 [No Abstract] [Full Text] [Related]
28. Central core disease associated with elevated creatine phosphokinase levels. Two members of a family known to be susceptible to malignant hyperpyrexia. Isaacs H; Barlow MB S Afr Med J; 1974 Mar; 48(15):640-2. PubMed ID: 4823722 [No Abstract] [Full Text] [Related]
29. [A genetic muscular creatine phosphokinase abnormality in a family with malignant hyperpyrexia]. Zsigmond EK; Starkweather WH; Duboff GS; Flyn K Rev Bras Anestesiol; 1971; 21(3):265-76. PubMed ID: 5138487 [No Abstract] [Full Text] [Related]
31. Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia. Meltzer HY; Hassan SZ; Russo P; Cho HW Anesth Analg; 1976; 55(6):797-9. PubMed ID: 1033694 [TBL] [Abstract][Full Text] [Related]
32. [Two cases of subclinical myopathy. Is it a trait for malignant hyperthermia? (author's transl)]. Sunohara N; Takagi A; Nonaka I; Satoyoshi E; Kojima S Rinsho Shinkeigaku; 1980 Jun; 20(6):448-54. PubMed ID: 7408344 [No Abstract] [Full Text] [Related]
33. The association of malignant hyperthermia and unusual disease: when you're hot you're hot or maybe not. Davis PJ; Brandom BW Anesth Analg; 2009 Oct; 109(4):1001-3. PubMed ID: 19762721 [No Abstract] [Full Text] [Related]
34. Creatine phosphokinase (CPK) levels in pregnancy: a case report and a discussion of the value of CPK levels in the prediction of possible malignant hyperpyrexia. Isherwood DM; Ridley J; Wilson J Br J Obstet Gynaecol; 1975 Apr; 82(4):346-9. PubMed ID: 1125158 [TBL] [Abstract][Full Text] [Related]
35. [Malignant hyperthermia--postoperative changes of serum LDH and CPK isozymes (author's transl)]. Shimonaka H; Yamamoto M Masui; 1981 Feb; 30(2):141-9. PubMed ID: 7277676 [No Abstract] [Full Text] [Related]
36. [Malignant hyperthermia]. Popinigis J; Brucker RF; Taylor CA; Williams CH Pol Tyg Lek; 1972 Aug; 27(33):1290-3. PubMed ID: 4562245 [No Abstract] [Full Text] [Related]
37. [Muscular enzyme level disorders and a malignant hyperthermia susceptability test: postoperative study of a patient with elevated CPK]. Perugini M; Montironi C; Rocchi S Minerva Anestesiol; 1998; 64(1-2):45-50. PubMed ID: 9658790 [TBL] [Abstract][Full Text] [Related]
39. [Malignant hyperthermia during an operation (a review of the literature)]. Chernokozhev Kh Khirurgiia (Sofiia); 1976; 29(1):64-9. PubMed ID: 772294 [No Abstract] [Full Text] [Related]
40. Histological, histochemical and ultramicroscopic findings in muscle biopsies from carriers of the trait for malignant hyperpyrexia. Isaacs H; Frere G; Mitchell J Br J Anaesth; 1973 Aug; 45(8):860-8. PubMed ID: 4753682 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]